Cargando…

Anticancer Activity of Novel NF-κB Inhibitor DHMEQ by Intraperitoneal Administration

There have been great advances in the therapy of cancer and leukemia. However, there are still many neoplastic diseases that are difficult to treat. For example, it is often difficult to find effective therapies for aggressive cancer and leukemia. An NF-κB inhibitor named dehydroxymethylepoxyquinomi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Umezawa, Kazuo, Breborowicz, Andrzej, Gantsev, Shamil
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cognizant Communication Corporation 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7751220/ https://www.ncbi.nlm.nih.gov/pubmed/32576339 http://dx.doi.org/10.3727/096504020X15929100013698

Ejemplares similares

Inhibition of Cellular and Animal Inflammatory Disease Models by NF-κB Inhibitor DHMEQ
por: Ma, Jun, et al.
Publicado: (2021)

Inhibition of Canonical NF-κB Nuclear Localization by (−)-DHMEQ via Impairment of DNA Binding
por: Horie, Kana, et al.
Publicado: (2015)

Enhancement of radiosensitivity by a unique novel NF-κB inhibitor, DHMEQ, in prostate cancer
por: Kozakai, N, et al.
Publicado: (2012)

Inhibition of MLCK‑mediated migration and invasion in human endometriosis stromal cells by NF‑κB inhibitor DHMEQ
por: Lin, Yinzhi, et al.
Publicado: (2023)

A novel NF-κB inhibitor, DHMEQ, ameliorates pristane-induced lupus in mice
por: QU, HUIQING, et al.
Publicado: (2014)

Inhibition of Late and Early Phases of Cancer Metastasis by the NF-κB Inhibitor DHMEQ Derived from Microbial Bioactive Metabolite Epoxyquinomicin: A Review
por: Lin, Yinzhi, et al.
Publicado: (2018)

The designed NF-κB inhibitor, DHMEQ, inhibits KISS1R-mediated invasion and increases drug-sensitivity in mouse plasmacytoma SP2/0 cells
por: Lin, Yinzhi, et al.
Publicado: (2021)

Inhibition of NF-κB Activity Enhances Sensitivity to Anticancer Drugs in Cholangiocarcinoma Cells
por: Seubwai, Wunchana, et al.
Publicado: (2016)

Anti-inflammatory effects of novel AP-1 and NF-κB inhibitors in dextran-sulfate-sodium-induced colitis in rats
por: EL-SALHY, MAGDY, et al.
Publicado: (2016)

Treatment with novel AP-1 and NF-κB inhibitors restores the colonic endocrine cells to normal levels in rats with DSS-induced colitis
por: EL-SALHY, MAGDY, et al.
Publicado: (2016)

Amelioration of Severe TNBS Induced Colitis by Novel AP-1 and NF-κB Inhibitors in Rats
por: El-Salhy, Magdy, et al.
Publicado: (2014)

Effects of AP-1 and NF-κB inhibitors on colonic endocrine cells in rats with TNBS-induced colitis
por: El-Salhy, Magdy, et al.
Publicado: (2016)

Immunosuppression through constitutively activated NF-κB signalling in human ovarian cancer and its reversal by an NF-κB inhibitor
por: Nishio, H, et al.
Publicado: (2014)

Differences in the Expression of TLR-2, NOD2, and NF-κB in Placenta Between Twins
por: Szylberg, Łukasz, et al.
Publicado: (2018)

AMPK-NF-κB Axis in the Photoreceptor Disorder during Retinal Inflammation
por: Kamoshita, Mamoru, et al.
Publicado: (2014)

Microenvironmental stromal cells abrogate NF-κB inhibitor-induced apoptosis in chronic lymphocytic leukemia
por: Simon-Gabriel, Carl Philipp, et al.
Publicado: (2018)

Mice lacking NF-κB1 exhibit marked DNA damage responses and more severe gastric pathology in response to intraperitoneal tamoxifen administration
por: Burkitt, Michael D, et al.
Publicado: (2017)

The Neuroprotective Effect of Rapamycin as a Modulator of the mTOR-NF-κB Axis during Retinal Inflammation
por: Okamoto, Tomohiro, et al.
Publicado: (2016)

Targeting DNA Binding for NF-κB as an Anticancer Approach in Hepatocellular Carcinoma
por: Chung, Po Yee, et al.
Publicado: (2018)

NF-κB inhibitor dehydroxymethylepoxyquinomicin suppresses osteoclastogenesis and expression of NFATc1 in mouse arthritis without affecting expression of RANKL, osteoprotegerin or macrophage colony-stimulating factor
por: Kubota, Tetsuo, et al.
Publicado: (2007)

Novel 1,3,4-Oxadiazole Induces Anticancer Activity by Targeting NF-κB in Hepatocellular Carcinoma Cells
por: Mohan, Chakrabhavi Dhananjaya, et al.
Publicado: (2018)

Aberrant Expression of NF-κB in Liver Fluke Associated Cholangiocarcinoma: Implications for Targeted Therapy
por: Seubwai, Wunchana, et al.
Publicado: (2014)

Author Correction: Mice lacking NF-κB1 exhibit marked DNA damage responses and more severe gastric pathology in response to intraperitoneal tamoxifen administration
por: Burkitt, M. D., et al.
Publicado: (2019)

NF-κB Inhibitors from Eurycoma longifolia
por: Tran, Thi Van Anh, et al.
Publicado: (2014)

Development of (4-Phenylamino)quinazoline Alkylthiourea Derivatives as Novel NF-κB Inhibitors
por: Darwish, Sarah S., et al.
Publicado: (2022)

In vitro and in vivo anticancer activity of Lycorine in prostate cancer by inhibiting NF-κB signaling pathway
por: Liu, Jie, et al.
Publicado: (2022)

Natural chalcones as dual inhibitors of HDACs and NF-κB
por: ORLIKOVA, B., et al.
Publicado: (2012)

Small Molecule NF-κB Pathway Inhibitors in Clinic
por: Ramadass, Venkataramanan, et al.
Publicado: (2020)

Enhanced NF-κB Activity Impairs Vascular Function Through PARP-1–, SP-1–, and COX-2–Dependent Mechanisms in Type 2 Diabetes
por: Kassan, Modar, et al.
Publicado: (2013)

Dehydroxymethylepoxyquinomicin, a novel nuclear factor-κB inhibitor, prevents the development of cyclosporine A nephrotoxicity in a rat model
por: Morita, Shinya, et al.
Publicado: (2020)

The novel NF-κB inhibitor IMD-0354 induces apoptosis in chronic lymphocytic leukemia
por: Kanduri, M, et al.
Publicado: (2011)

NF-κB drives acquired resistance to a novel mutant-selective EGFR inhibitor
por: Galvani, Elena, et al.
Publicado: (2015)

The TCL1A Oncoprotein Interacts Directly with the NF-κB Inhibitor IκB
por: Ropars, Virginie, et al.
Publicado: (2009)

Differential regulation of NF-κB activation and function by topoisomerase II inhibitors
por: Campbell, Kirsteen J, et al.
Publicado: (2006)

Growth Inhibitory Effects of Dipotassium Glycyrrhizinate in Glioblastoma Cell Lines by Targeting MicroRNAs Through the NF-κB Signaling Pathway
por: Bonafé, Gabriel Alves, et al.
Publicado: (2019)

Intra-articular administration of IκBα kinase inhibitor suppresses mouse knee osteoarthritis via downregulation of the NF-κB/HIF-2α axis
por: Murahashi, Yasutaka, et al.
Publicado: (2018)

The effects of pentoxifylline administration on NFΚB P50 transcription factor expression
por: Shamsara, Jamal, et al.
Publicado: (2012)

Intrapulmonary administration of purified NEIL2 abrogates NF-κB–mediated inflammation
por: Tapryal, Nisha, et al.
Publicado: (2021)

Effect of a small molecule inhibitor of nuclear factor-κB nuclear translocation in a murine model of arthritis and cultured human synovial cells
por: Wakamatsu, Kyoko, et al.
Publicado: (2005)

Polymorphisms in NF-κB Inhibitors and Risk of Epithelial Ovarian Cancer
por: White, Kristin L, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_7c7poiao4cu4064pa3mtil61gn